Make Better Decisions - Finding and Evaluating Generic and Branded Drug Market Entry Opportunities

Get the Book: Make Better Decisions

Finding and Evaluating Generic and Branded Drug Market Entry Opportunities

PDF eBook: Just $10 Get Print Book on Amazon

Serving leading biopharmaceutical companies globally:

Mallinckrodt
Medtronic
Merck
McKinsey
Baxter
Moodys

Last Updated: October 14, 2019

DrugPatentWatch Database Preview

Roxane Company Profile

See Plans and Pricing

« Back to Dashboard

What is the competitive landscape for ROXANE, and what generic and branded alternatives to ROXANE drugs are available?

ROXANE has one hundred and twenty-eight approved drugs.

There are fifteen tentative approvals on ROXANE drugs.

Drugs and US Patents for Roxane

Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Exclusivity Expiration
Roxane TRIAMCINOLONE triamcinolone TABLET;ORAL 084709-001 Approved Prior to Jan 1, 1982 DISCN No No   See Pricing   See Pricing
Roxane PROPRANOLOL HYDROCHLORIDE propranolol hydrochloride TABLET;ORAL 070519-001 Sep 24, 1986 DISCN No No   See Pricing   See Pricing
Roxane LOPERAMIDE HYDROCHLORIDE loperamide hydrochloride CAPSULE;ORAL 073080-001 Nov 27, 1991 DISCN No No   See Pricing   See Pricing
Roxane HYDROCHLOROTHIAZIDE hydrochlorothiazide TABLET;ORAL 085004-001 Approved Prior to Jan 1, 1982 DISCN No No   See Pricing   See Pricing
Roxane AMINOPHYLLINE aminophylline SOLUTION;ORAL 088126-001 Aug 19, 1983 DISCN No No   See Pricing   See Pricing
>Applicant >Tradename >Generic Name >Dosage >NDA >Approval Date >TE >Type >RLD >RS >Patent No. >Patent Expiration >Product >Substance >Delist Req. >Exclusivity Expiration
Similar Applicant Names
Applicants may be listed under multiple names.
Here is a list of applicants with similar names.

Make Better Decisions: Try a trial or see plans & pricing

Serving leading biopharmaceutical companies globally:

Harvard Business School
Express Scripts
Dow
McKinsey
Merck
Johnson and Johnson

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.